Form 4: Insulet Corp SVP Mark N. Field Sells Shares

Mark N. Field, SVP & Chief Technology Officer of Insulet Corp, sold 2,131 shares of common stock at an average price of $190.43 on June 10, 2024.

Summary

• On June 10, 2024, Mark N. Field, the SVP & Chief Technology Officer of Insulet Corp, sold 2,131 shares of common stock.
• The sale was executed at a weighted average price of $190.43 per share, with individual sales ranging from $190.33 to $190.49.
• Following the transaction, Field directly owns 14,375 shares of Insulet Corp.
• This total includes 130 shares acquired through the Insulet Corporation Employee Stock Purchase Plan on May 31, 2024.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. It doesn't convey any explicit positive or negative sentiment about the company's performance or prospects.

Industry Context

This filing is a routine disclosure of insider trading activity, which is common for executives of publicly traded companies. It provides transparency to investors regarding the transactions of company insiders.

Comparison to Industry Standards

• Insider trading activity is a common occurrence in publicly traded companies like Insulet Corp.
• Similar filings are regularly made by executives at comparable companies such as Dexcom (DXCM) and Abbott Laboratories (ABT).
• The scale of this transaction (2,131 shares) is relatively small compared to some insider sales, suggesting it may be part of routine portfolio management rather than a significant strategic move.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, but the relatively small size of the transaction suggests it is unlikely to have a significant impact.

Key Dates